Drug-induced nail disorders - Incidence, management and prognosis

被引:45
|
作者
Piraccini, BM [1 ]
Tosti, A [1 ]
机构
[1] Univ Bologna, Dept Dermatol, I-40136 Bologna, Italy
关键词
D O I
10.2165/00002018-199921030-00004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A large number of drugs of different classes, ranging from antibacterials to chemotherapeutic agents to psoralens, can be responsible for the development of nail changes. Drug-induced nail changes usually involve several or all 20 nails and appear in temporal correlation with drug intake. Some nail changes are asymptomatic and only cause cosmetic problems, while others cause pain and discomfort and impair manual activities or deambulation. Drug-induced nail abnormalities are usually transitory and disappear with drug withdrawal, but sometimes persist in time. The pathogenesis of the nail changes is usually a toxic effect of the drug on the different nail constituents. but other mechanisms can be involved. Drugs that are well known to produce nail abnormalities include cancer chemotherapeutic agents, psoralens, retinoids, tetracyclines, antimalarials and zidovudine. Arsenic poisoning is also always associated with nail changes that have medico-legal importance. Some drugs taken during pregnancy may impair nail development of the fetus, and nail hypoplasia or other nail dystrophies will be evident in the newborn.
引用
下载
收藏
页码:187 / 201
页数:15
相关论文
共 50 条
  • [31] Drug-induced thrombotic microangiopathy - Incidence, prevention and management
    Pisoni, R
    Ruggenenti, P
    Remuzzi, G
    DRUG SAFETY, 2001, 24 (07) : 491 - 501
  • [32] Drug-induced hyperhidrosis and hypohidrosis - Incidence, prevention and management
    Cheshire, William P., Jr.
    Fealey, Robert D.
    DRUG SAFETY, 2008, 31 (02) : 109 - 126
  • [33] Drug-Induced Lupus Erythematosus Incidence, Management and Prevention
    Chang, Christopher
    Gershwin, M. Eric
    DRUG SAFETY, 2011, 34 (05) : 357 - 374
  • [34] Drug-induced diabetes insipidus - Incidence, prevention and management
    Bendz, H
    Aurell, M
    DRUG SAFETY, 1999, 21 (06) : 449 - 456
  • [35] Drug-induced disorders
    Friedman, M
    AMERICAN FAMILY PHYSICIAN, 1998, 57 (11) : 2615 - 2615
  • [36] Drug-induced disorders
    Holland, EG
    Degruy, FV
    AMERICAN FAMILY PHYSICIAN, 1997, 56 (07) : 1781 - 1788
  • [37] Drug-Induced Cognition Disorders in the ElderlyIncidence, Prevention and Management
    Shelly L. Gray
    Katie V. Lai
    Eric B. Larson
    Drug Safety, 1999, 21 : 101 - 122
  • [38] Drug-induced disorders of glucose metabolism - Mechanisms and management
    Chan, JCN
    Cockram, CS
    Critchley, JAJH
    DRUG SAFETY, 1996, 15 (02) : 135 - 157
  • [39] Drug-induced and traumatic nail problems in the haemophilias
    Heim, M
    Schapiro, J
    Wershavski, M
    Martinowitz, U
    HAEMOPHILIA, 2000, 6 (03) : 191 - 194
  • [40] Psychotropic Drug-Induced Sexual Function DisordersDiagnosis, Incidence and Management
    David O. Clayton
    Winston W. Shen
    Drug Safety, 1998, 19 : 299 - 312